nach oben

Journal of Public Health

Erschienen in:

01.08.2008 | Original Article

Improving vaccination programmes in the European Union

verfasst von: Pier Luigi Lopalco

Erschienen in: Journal of Public Health | Ausgabe 4/2008

Einloggen, um Zugang zu erhalten

Abstract

Aim

In this article, we describe what the role of the European Centre for Disease Control and Prevention (ECDC) is and should be in supporting national vaccination programmes and improving the exchange of data and best practice.

Subjects and methods

On the basis of information provided to the ECDC by two networks (EUVAC, VENICE) as well as the World Health Organisation (WHO) data, we examine childhood vaccination programmes in the European Union (EU), components of national vaccination programmes, and decision-making processes both at regulatory (EU) and epidemiological, socio-economic (national) levels.

Results

The ECDC provides added value to national vaccination policies by sharing data in the areas of epidemiology, vaccination coverage, vaccine schedules and schemes, and evaluation of national programmes.

Conclusion

National sovereignty in the field of vaccination policy should prevail; however, international support is paramount if we wish to enhance performance by sharing experience.

Centralised Information System for Infectious Diseases (CISID) web site. Accessible at: http://data.euro.who.int/CISID/

Decision No 2119/98/EC of the European Parliament and of the Council of 24 September 1998 setting up a network for the epidemiological surveillance and control of communicable diseases in the Community. Accessible at: http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexapi!prod!CELEXnumdoc&lg=EN&numdoc=31998D2119&model=guicheti

European Medicine Agency web site. Accessible at: http://www.emea.europa.eu

EUVAC.NET web site. Accessible at: http://www.euvac.net/graphics/euvac/index.html

EUVAC.NET web site. Accessible at: http://www.euvac.net/graphics/euvac/vaccination/vaccination.html

EUVAC.NET web site. Accessible at: http://www.euvac.net/graphics/euvac/vaccination/pcv7.html

EUVAC.NET web site. Accessible at: http://www.euvac.net/graphics/euvac/vaccination/menc.html

Guide to community preventive services. Accessible at: http://www.thecommunityguide.org/vaccine/default.htm

Regulation (EC) No 851/2004 of the European Parliament and of the Council of 21 April 2004 establishing a European Centre for disease prevention and control. Accessible at: http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexapi!prod!CELEXnumdoc&lg=EN&numdoc=32004R0851&model=guicheti

Siegrist CA, Balinska MA (2008) The public perception of the value of vaccines. J Public Health

The Treaty of the European Union, consolidated version. Accessible at: http://eur-lex.europa.eu/en/treaties/dat/12002E/htm/C_2002325EN.003301.html)

VENICE web site. Accessible at: https://venice.cineca.org/

WHO European Region strategic plan, 2005–2010: Eliminating measles and rubella and preventing congenital rubella infection. Accessible at: http://www.euro.who.int/InformationSources/Publications/Catalogue/20051123_1

Titel: Improving vaccination programmes in the European Union
verfasst von: Pier Luigi Lopalco
Publikationsdatum: 01.08.2008
Verlag: Springer-Verlag
Erschienen in: Journal of Public Health / Ausgabe 4/2008
Print ISSN: 2198-1833
Elektronische ISSN: 1613-2238
DOI: https://doi.org/10.1007/s10389-008-0198-5

Springer Medizin

Abstract

Aim

Subjects and methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2008

The Finnish decision-making process to recommend a new vaccine: From vaccine research to vaccination policy

The introduction of policies for human papillomavirus vaccination in Europe

Public health economics of vaccines in the Netherlands: methodological issues and applications

How do we tackle the complex field of vaccinology in the twenty-first century?

Funding processes for new vaccines: the need for greater understanding of the economic issues

The role of scientific societies in the decision-making process to recommend new vaccines: the example of rotavirus in Europe